| RANKL | Receptor activator of nuclear factor kappa-B ligand |
| TNF-α | Tumor necrosis factor-alpha |
| OPCs | Osteoclast precursor cells |
| OSCC | Oral squamous cell carcinoma |
| NFATc1 | Nuclear factor of T cell c1 |
| IL-1 | Interleukin 1 |
| IL-6 | Interleukin 6 |
| PTHrP | Parathyroid hormone related peptide |
| BRONJ | Bisphosphonate-related osteonecrosis of the jaw |
| MRONJ | Medication related osteonecrosis of the jaw |
| OPG | Osteoprotegerin |
| CBD | Cannabidiol |
| DMA | Dimethyl amiloride |
| MVs | Microvesicles |
| 2-AG | 2-arachidonoylglycerol |
| CB1 | Cannabinoid receptor type 1 |
| CB2 | Cannabinoid receptor type 2 |
| TRPV1 | Transient receptor potential vanilloid type 1 |
| TRAP | Tartrate-resistant acid phosphatase |